Dashboard
Financial statements
RVTY

Company financials

Revvity

Health Care Health Care Equipment Waltham, Massachusetts Last filing Feb 24, 2026 · FY2025
Revenue FY2025
$2.9B
3y CAGR -4.8% P7
Net income FY2025
$241.2M
Net margin +8.4% P37
Total assets FY2025
$12.2B
ROA +2.0% P12
Operating cash flow FY2025
$582.9M
FCF margin +17.8% P61
18 yrs · FY2008–FY2025 9 filed · 0 derived · 0 blank

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

31 accounts · 10 years
Total assets $12.2B
Total liabilities $4.9B
Shareholders equity $7.3B
Account 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Trend
Assets
Cash and Cash Equivalents 32.2% 42.2% 33.2% 13.7% 15.8% 14.5% 6.7% 5.9% 9.0% 17.0%
Accounts Receivable 26.1% 23.0% 23.0% 18.5% 18.5% 43.4% 25.1% 22.8% 24.5% 20.1%
Inventory 13.3% 15.6% 15.6%
Prepaid Expenses 6.9% 12.3% 4.2%
Other Current Assets 6.9% 12.3% 4.2%
Total Current Assets 78.4% 85.3% 109.1% 99.3% 63.8% 84.1% 47.7% 44.4% 53.2% 56.2%
Property,Plant and Equipment 16.8% 17.5% 18.5% 14.6% 12.7% 13.8% 11.0% 11.5% 13.2% 6.9%
Operating Lease Assets 5.8% 6.1% 5.6% 5.7% 4.3% 7.8% 5.8%
Goodwill 231.6% 234.6% 237.5% 195.7% 173.1% 99.1% 107.9% 106.3% 133.0% 106.3%
Intangible Assets 82.2% 109.9% 59.7%
Other Noncurrent Assets 11.3% 10.5% 12.5% 9.4% 8.3% 12.5% 9.9% 9.7% 10.8% 9.7%
Total Assets 426.1% 449.8% 493.2% 426.6% 391.9% 298.9% 226.7% 215.1% 269.9% 202.2%
Liabilities
Accounts Payable 6.5% 6.1% 7.4% 8.2% 8.5% 12.3% 8.2% 8.0% 9.8% 7.9%
Accrued Liabilities 19.5% 17.6% 19.1% 15.9% 17.7% 35.4% 17.5% 19.0% 22.2% 18.9%
Deferred Revenue 5.6% 4.9% 7.1%
Current Portion of Long Term Debt 20.6% 26.2%
Operating Lease Liabilities 5.2% 4.8%
Other Current Liabilities 28.3% 33.8% 37.6%
Total Current Liabilities 46.6% 23.7% 52.7% 46.6% 31.7% 62.0% 26.5% 27.8% 42.1% 28.5%
Long Term Debt 92.1% 114.4% 115.5% 118.5% 130.1% 60.4% 71.6% 67.6% 79.3% 49.4%
Deferred Revenue Noncurrent 5.6% 4.9% 7.1%
Operating Lease Liabilities Noncurrent 5.2% 5.5% 4.8% 5.1% 3.9% 7.1% 5.1% 0.0%
Other Noncurrent Liabilities 28.3% 28.0% 33.8% 33.5% 37.3% 29.1% 26.1% 26.7% 37.6% 21.7%
Total Liabilities 172.2% 171.5% 206.9% 203.7% 205.3% 158.6% 129.2% 122.1% 159.0% 100.4%
Equity
Preferred Stock 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Common Stock 3.9% 4.4% 4.5% 3.8% 3.3% 4.2% 3.9% 4.0% 4.9% 5.2%
Additional Paid In Capital 45.7% 76.1% 87.9% 83.1% 72.1% 5.6% 3.1% 1.8% 2.6% 1.2%
Retained Earnings 212.0% 203.9% 105.5%
Accumulated Other Comprehensive Income -7.8% -10.1% -2.1%
Total Stockholders Equity 253.9% 278.3% 286.2% 222.9% 186.6% 140.3% 97.6% 93.1% 110.9% 101.8%
Total Liabilitiesand Equity 426.1% 449.8% 493.2% 426.6% 391.9% 298.9% 226.7% 215.1% 269.9% 202.2%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 10 years
Ratio 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Profitability
Gross margin +68.6%
Operating margin +12.5% +12.6% +10.9% +22.4% +32.9% +32.6% +12.6% +11.7% +13.1% +13.9%
Net margin +8.4% +9.8% +25.2% +17.2% +24.6% +27.3% +7.9% +8.6% +13.0% +11.1%
FCF margin +17.8% +21.0% +0.4% +17.7% +32.5% +24.1% +10.0% +7.8% +11.0% +13.8%
Growth
Revenue CAGR (3y) -4.8% -10.4% +1.1% +4.7% +11.3% +5.7% +10.9% +9.7% +0.3% -0.7%
Returns
ROE +3.3% +3.5% +8.8% +7.7% +13.2% +19.5% +8.1% +9.2% +11.7% +10.9%
ROA +2.0% +2.2% +5.1% +4.0% +6.3% +9.1% +3.5% +4.0% +4.8% +5.5%
ROIC +3.3% +3.6% +2.7% +6.6% +10.9% +16.2% +7.7% +7.5% +3.8% +10.4%
Liquidity
Current ratio 1.68x 3.60x 2.07x 2.13x 2.01x 1.36x 1.80x 1.60x 1.26x 1.97x
Quick ratio 1.25x 2.75x 1.07x 0.69x 1.08x 0.93x 1.20x 1.03x 0.79x 1.30x
Leverage
D/E 0.68x 0.62x 0.72x 0.91x 1.10x 1.13x 1.32x 1.31x 1.43x 0.99x
Interest coverage 3.87x 3.04x 17.45x 5.69x 4.84x 6.73x 7.09x
Efficiency
Asset turnover 0.23x 0.22x 0.20x 0.23x 0.26x 0.33x 0.44x 0.46x 0.37x 0.49x
Cash conversion cycle +156d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds RVTY to your watchlist.